Czasopismo Clinical and Experimental Hepatology 2020

Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression

Krishna Chaitanya Thandra, Adam Barsouk, Kalyan Saginala, John Sukumar Aluru, Prashanth Rawla, Alexander Barsouk

Clin Exp HEPATOL 2020; 6, 4: 289–294

DOI: https://doi.org/10.5114/ceh.2020.102153

Abstract View text

Factors predicting recovery of liver function after percutaneous drainage in malignant biliary obstruction: the role of hospital-acquired biliary sepsis

Suneed Kumar, Shakeel Masood, Utkarsh Srivastava, Shibumon M. Madhavan, Smita Chauhan, Anshuman Pandey

Clin Exp HEPATOL 2020; 6, 4: 295–303

DOI: https://doi.org/10.5114/ceh.2020.102154

Abstract View text

Impact of liver-directed therapy and non-therapy on the waiting time list of patient candidates for liver transplantation: retrospective survival analysis

Maria del Pilar Bayona Molano, Lorena Garza, Genaro Selvaggi, Jay Vasani, Juan Carlos Barrera Gutierrez, Jason Salsamendi, Shivank Bhatia, Leopoldo Arosemena

Clin Exp HEPATOL 2020; 6, 4: 304–312

DOI: https://doi.org/10.5114/ceh.2020.102175

Abstract View text

Study of predictive factors of complete response after chemoembolization for unresectable hepatocellular carcinoma in 162 patients

El Hassani Younes, Hamdoun Fatima Zahra, Ben Maamar Soumaya, Lahlali Maria, Lahmidani Nada, Abid Hakima, El Fakir Samira, Haloua Meriem, Alami Badreddine, Hafidi Youssef, Kamaoui Imane, Boubbou Meryem, Aqodad Noureddine, Ibrahimi Sidi Adil, Maaroufi Mustapha, Alaoui Lamrani Moulay Youssef

Clin Exp HEPATOL 2020; 6, 4: 313–320

DOI: https://doi.org/10.5114/ceh.2020.102169

Abstract View text

Epidemiological investigation on hepatitis A virus infection outbreak in the area of Rzeszow city during the years 2017/18

Andrzej Cieśla, Monika Bociąga-Jasik, Jerzy Sieklucki, Robert Pleśniak

Clin Exp HEPATOL 2020; 6, 4: 321–326

DOI: https://doi.org/10.5114/ceh.2020.102176

Abstract View text

Hepatic ballooning degeneration: a new feature of the refeeding syndrome in rats

Alceu Afonso Jordao, Amanda Canale, Mariângela Brunaldi, Sergio Zucoloto

Clin Exp HEPATOL 2020; 6, 4: 327–334

DOI: https://doi.org/10.5114/ceh.2020.102151

Abstract View text

FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients

Khaled Metwally, Maha Elsabaawy, Mohamed Abdel-Samiee, Wessam Morad, Nermine Ehsan, Eman Abdelsameea

Clin Exp HEPATOL 2020; 6, 4: 335–338

DOI: https://doi.org/10.5114/ceh.2020.102157

Abstract View text

SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review

Michael Dwinata, David Dwi Putera, Irsan Hasan, Monica Raharjo

Clin Exp HEPATOL 2020; 6, 4: 339–346

DOI: https://doi.org/10.5114/ceh.2020.102173

Abstract View text

Whole exome sequencing analysis for mutations in isolated type III biliary atresia patients

Kubilay Gürünlüoğlu, Ahmet Koç, Kübra Durmuş, Harika Gözükara Bağ, Canan Ceran, Semra Gürünlüoğlu, Turan Yıldız, Mehmet Gül, Mehmet Demircan

Clin Exp HEPATOL 2020; 6, 4: 347–353

DOI: https://doi.org/10.5114/ceh.2020.102156

Abstract View text

Physician awareness of hepatitis C virus among different departments

Tolga Düzenli, Hüseyin Köseoğlu

Clin Exp HEPATOL 2020; 6, 4: 354–358

DOI: https://doi.org/10.5114/ceh.2020.102155

Abstract View text

Association between interleukin 6 polymorphisms (rs1800796, rs1800795, rs2069837, rs17147230, and rs1800797) and hepatocellular carcinoma susceptibility: a meta-analysis

Omid Emami Aleagha, Pembe Oltulu, Masoud Sadeghi

Clin Exp HEPATOL 2020; 6, 4: 359–366

DOI: https://doi.org/10.5114/ceh.2020.102171

Abstract View text

Hepatic interferon γ and tumor necrosis factor a expression in infants with neonatal cholestasis and cytomegalovirus infection

Himali Meshram, Shilpa Velhal, Varsha Padwal, Jyoti Sutar, Ravi Kadam, Jacinta Pereira, Gauri Bhonde, Kalyani Karandikar, Vikrant Bhor, Vainav Patel, Naman S. Shetty, Ira Shah

DOI: https://doi.org/10.5114/ceh.2020.102172

Abstract View text

Comparison of knowledge and awareness between consultant physicians and resident doctors about non-alcoholic fatty liver disease

Anurag Shrikant Lavekar, Aditi Deshpande, Dhananjay Raje

Clin Exp HEPATOL 2020; 6, 4: 374–383

DOI: https://doi.org/10.5114/ceh.2020.102152

Abstract View text

Ratio of cord blood bilirubin and albumin as predictors of neonatal hyperbilirubinaemia

Indra Kumar Sharma, Dinesh Kumar, Astitva Singh, Tariq Mahmood

DOI: https://doi.org/10.5114/ceh.2020.102170

Abstract View text

Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression

Factors predicting recovery of liver function after percutaneous drainage in malignant biliary obstruction: the role of hospital-acquired biliary sepsis

Impact of liver-directed therapy and non-therapy on the waiting time list of patient candidates for liver transplantation: retrospective survival analysis

Study of predictive factors of complete response after chemoembolization for unresectable hepatocellular carcinoma in 162 patients

Epidemiological investigation on hepatitis A virus infection outbreak in the area of Rzeszow city during the years 2017/18

Hepatic ballooning degeneration: a new feature of the refeeding syndrome in rats

FIB-5 versus FIB-4 index for assessment of hepatic fibrosis in chronic hepatitis B affected patients

SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review

Whole exome sequencing analysis for mutations in isolated type III biliary atresia patients

Physician awareness of hepatitis C virus among different departments

Association between interleukin 6 polymorphisms (rs1800796, rs1800795, rs2069837, rs17147230, and rs1800797) and hepatocellular carcinoma susceptibility: a meta-analysis

Hepatic interferon γ and tumor necrosis factor a expression in infants with neonatal cholestasis and cytomegalovirus infection

Comparison of knowledge and awareness between consultant physicians and resident doctors about non-alcoholic fatty liver disease

Ratio of cord blood bilirubin and albumin as predictors of neonatal hyperbilirubinaemia

Coverage in

Integrated with

Editorial Policies